Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel ...

Issuing a draft list of revised risk-based classification of cardiovascular and neurological devices, the Central Drugs ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

HYDRA-PMCF-study evaluated hygh-tec®, a new polyurethane fecal management systemhygh-tec® showed a high level of sealing performance (no leakage ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access to the Shockwave systems through a $13.1bn acquisition of Shockwave Medical ...

Advanced Medical Balloons GmbH (AMB), a specialist in medical technology from Waghaeusel near Heidelberg, today announced hygh-tec Odor Solution™ as an innovative addition to its hygh-tec™ catheter ...

The company develops and markets novel catheter technology based on microscopically thin, complex shaped balloon films made ... platform concepts in the Fecal, Urinary and Respiratory segments.